The extracted oil from Nigella sativa seeds is reported to be effective against various diseases and chemicallyinduced hepatotoxicity and nephrotoxicity. The effect of oral administration of Nigella sativa total, polar and neutral oils was investigated on hepatoprotective status in streptozotocin/nicotinamide (STZ-N)-induced diabetic rats. The toxicity was assessed biochemically by monitoring aspartate transaminase (AST), alanine transaminase (ALT), gamma-glutamyl transpeptitase (γ-GT) and alkaline phosphatase (AP) activities as well as biluribin titre and histologically under light microscope. The study was also undertaken to evaluate the effect of oil fractions on the regeneration of pancreatic Langerhans islets in treated diabetic rats. Biochemical analysis showed that lipid fractions from total oil of Nigella sativa seeds are not hepatotoxic. However, histological study of the liver demonstrated major and minor tissue damages with the neutral fraction exhibiting the most protective effect. At the end of the experiment period (17 days) of treatment with thymoquinone (25mg/kg bw/day) or neutral lipid fraction (100mg/kg bw/day), a positive effect on the regenerative of Langerhans islets, initially distorted by STZ, was observed. Thus, the hypoglycaemic effect of neutral lipid fraction could be a result of the regeneration of the pancreatic Langerhans islets.
Introduction
The hypoglycaemic effect of the seeds and oil of Nigella sativa Linn, family Ranunculaceae, an annual medicinal plant widely used in traditional medicine all over the world, is well documented. Different studies indicate that various extracts from the seeds and its major phenolic compound, thymoquinone, exhibit an anti-diabetic activity by either decreasing the levels of both blood glucose and lipids or increasing the release of insulin (1) (2) (3) or by the inhibitory effect on intestinal glucose absorption (4, 5) .
Beside the well established strong antioxidant properties, the oil of Nigella sativa seeds was effective against various diseases and chemically-induced hepatotoxicity and nephrotoxicity (6) . The protective effect of the oil of Nigella sativa seeds and thymoquinone on liver and Langerhans islets was described in many studies (7, 8) . In fact, it was reported that Nigella sativa seeds uptake decreases lipid peroxidation, increases the antioxidant defence system and also prevents the lipid-peroxidation-induced liver damage in experimentally induced diabetic rabbits (9) .
Volatile oil of Nigella sativa seeds reduces the level of glucose in streptozotocin/nicotinamide (STZ-N)-induced diabetic hamster and increases the rate of insulin production (10) . Few years later, it has been reported that thymoquinone reduces the level of blood glucose and its hepatic production through a decrease in hepatic gluconeogenesis (11) . The administration of Correspondence to: Widad SOBHI, Department of Physical and Chemical Biology, Faculty of Life and Nature Sciences, University of Bejaia, Targa Ouzermour, 06000 Bejaia, Algeria, Tel. + 213 (0) 553688956. E-mail: sobhiwidad@yahoo.fr 3mg/kg bw/day of thymoquinone abrogates the hyperglycaemic and hypo-insulinemic response to STZ in rats (8) . Administration of volatile oil of Nigella sativa seeds prior to STZ induction of diabetes gave a protective effect by decreasing lipid peroxidation and serum nitric oxide (NO), and increasing antioxidant enzyme activity in diabetic rats with an increase in staining intensity for insulin and the number of preserved β-cell (2, 12) . Increasing glucose-induced insulin release from the β-cells of the Langerhans islets was also observed by using defatted whole extract and basic subfractions of the Nigella sativa seeds (13) . The effect of total oil of Nigella sativa seeds on rat blood homeostasis and its hepatotoxicity has been well investigated (14, 15) . Tested on isolated rat hepatocytes, thymoquinone (1mM) was found to be a hepato-protective agent, by reducing the leakage of cytosolic enzymes, alanine transaminase (ALT) and aspartate transaminase (AST), against the toxicity induced by t-butyl hydroperoxide (TBHP) (7) .
Recently, Kanter reported that Nigella sativa and thymoquinone therapy causes morphologic improvement in neurodegeneration in frontal cortex, brain stem and hippocampus after chronic toluene exposure in rats (16, 17) . Nigella sativa and thymoquinone, used in the treatment of STZ-induced diabetic rats, increased significantly the area of insulin immunoreactive -cells and the histological evaluation of the tissues in treated diabetic animals showed fewer morphologic alterations (17, 18) . Thymoquinone demonstrated cyto-and genotoxic effects in a concentration-dependent manner (19) .
As far as we are aware of, up to date no hepatotoxicity effect of Nigella sativa oil was reported. In this study, by looking at the biochemical hepatic markers and histologically on liver slides, we investigated the hepatotoxicity effect of Nigella sativa total oil, polar and neutral lipid fractions of total oil and thymoquinone. In parallel, we looked at the regenerative effect of these compounds on Langerhans islets in STZ-N-induced diabetic rats with comparison to the anti-diabetic drug metformin.
Material and methods

Plant materials and extraction procedure
Nigella sativa seeds were purchased from a local herb store in Bejaia, Algeria, and identified by Doctor Benabdelmoumene in the laboratory of plant biology (University of Bejaia, Algeria) where specimens are deposited for future reference. The seeds were powdered in a mixer. 40 g of the powdered seeds were added to 200 ml of methanol and extraction was carried out by steam distillation and dried under vacuum. The obtained extract was subject to a second extraction with the organic solvent hexane (three times 50 ml) then dried yielding a defatted methanolic extract and the lipid fractions.
The total oil was then applied on a silica gel 60 G (70-230 mesh, Merck) column (30cmx3cm). The total neutral lipid fraction (TNLF) was eluted by chloroform (5x100ml), whereas the total polar lipid fraction (TPLF) was obtained by acetone-methanol (50:50, 5x100ml).
Induction of diabetes Animals:
Female healthy albino rats of Wistar strain, aged 8 weeks and weighting between 180 and 220g, were obtained from the Centre for Research and Development (CRD) at the pharmaceutical group company SAIDAL (Algiers, Algeria). They were housed in plastic cages with a 12/12-h light/dark cycle at an ambient temperature of 22-24°C and humidity of approximately 50%. Animals were fed standard diet and water ad libitum. All experiments were in compliance with the guidelines for the care and use of laboratory animals published by the US National Institute of Health (NIH publication No 85-23, revised 1985) with approval of SAIDAL ethic committee.
Experimental protocol:
Prior to experimentation, rats were maintained for three weeks on a normal diet before inducing diabetes by administration of N/STZ. The rats were randomly allotted into one of seven experimental groups:
Group I: control Group II: diabetic untreated Group III: diabetic treated with 100mg/kg bw/day of total volatile oil Group IV: diabetic treated with 100mg/kg bw/day of total polar lipids Group V: diabetic treated with 100mg/kg bw/day of total neutral lipids Group VI: diabetic treated with 25 mg/kg bw/day of thymoquinone Group VII: diabetic treated with 25 mg/kg bw/day of metformin Diabetes was induced in all groups except group A by a single intra-peritoneal injection of nicotinamide (230 mg/kg) followed, after 15min, by a single intraperitoneal injection of STZ (65 mg/kg) freshly dissolved in 5mmol/L citrate buffer, pH 4.5 (2,12) according to the protocol reported by Masiello and co-workers (20) with slight modification. Animals of group I (control normal rats) and of group II (untreated diabe-tic rats) received daily a volume of tap water equivalent to administered treatment volumes by intra-gastric gavage. Two days after STZ-N treatment, development of diabetes was confirmed by measuring blood glucose levels in a tail vein blood samples. Rats with blood glucose levels of 110 mg/dl or higher were considered as diabetic and included for the study. Serum glucose levels in control animals remained normal for the duration of the study (17 days). We took advantage of the partial protection of nicotinamide against the betacytotoxic effect of STZ to create a new experimental diabetic syndrome in adult rats that appears closer to non insulin-dependent diabetes mellitus (NIDDM) or type 2. This model compared to other available animal models, with regard to insulin responsiveness to glucose and sulfonylureas, yielded a maximum of animals with moderate and stable non-fasting hyperglycemia with a partial preservation of pancreatic insulin stores.
Biochemical analysis
Five days after N/STZ administration, we confirmed the development of diabetes by measuring the blood glucose using the glucose oxidase method (kit from Elitech Diagnostic, France) on overnight fasted rats. Animals showing fasting blood sugars (FBS) more than 110 mg/dl were considered as diabetic and included in the study.
At the end of experimental period (17 th day), rats were fasted overnight and blood was taken, centrifuged and serum separated. Effect of each fraction on FBS level was evaluated. Serum levels of transaminases ALT and AST (kits QCA.S.A, Spain) were determined according to Bergmeyer method (21), gamma-glutamyl transpeptidase (γ-GT) (kits, QCA.S.A, Spain) was determined according to the Szass methods (1969), total bilirubin (kits, QCA.S.A, Amposta /Spain) according to the Jandrassik-Grof method (22) modified by Doumas (23) and alkaline phosphatase (AP) (kits, QCA.S.A, Amposta/Spain) according to the method described by Hausamen and his collaborators (24) . Results were compared with that of tymoquinone and standard antidiabetic drug metformin.
Histopathological procedures
After the blood sample collection, all animals were killed under pentobarbital anaesthesia (60 mg/kg bw; Sigma, Poole, UK). Liver and pancreatic tissues were harvested and tissue fragments were fixed in 10% neutral formalin solution, embedded in paraffin, and sectioned at 3µm thickness using a microtome (Leica Microsystems, Leica RM 2125 RT). Slices were treated with xylene and ethanol, and then stained with haematoxylin and eosin (H&E). The preparations were evaluated by means of an optical bright-field microscope and photographed (Optiphot 2, Nikon, Tokyo, Japan).
Statistical analysis
The results were expressed as Mean ± SEM. The Student's t-test was used for analyzing the data between treated and control groups. Values of p <0.05 were considered statistically significant.
Results
The use of N-STZ has induced diabetes in all rats but glycaemia was not as high as reported previously when induced by STZ alone (2, 8, 9, 11, 12, 25, 26) . This is due to the protective effect of nicotinamide (230mg/kg bw) on the pancreatic β cells, to an extent Table 1 . Measurement of the hepatic activity of four enzymes and bilirubin concentrations in serum of normal, diabetic, and diabetic treated with total oil, polar and neutral lipid fractions of Nigella sativa seeds, in rats. Group I: normal rats, Group II: diabetic rats, Group III: diabetic rats treated with 100mg/kg bw/day of total oil of Nigella sativa seeds, Group IV: diabetic rats treated with 100mg/kg bw/day of polar fraction of Nigella sativa seeds total oil, Group V: diabetic rats treated with 100mg:kg bw/day of neutral fraction total oil of Nigella sativa seeds, Group VI: diabetic rats treated with 25mg/kg bw/day of thymoquinone, Group VII: diabetic rats treated with 25mg/kg bw /day of metformin. Each group contains 7 rats. AST = aspartate transaminase, ALZ = alanine transaminase, γ-GT = gamma-glutamyl transpeptidase, AP = alkaline phosphatase Effect of Nigella sativa extract on liver tissue, Histology of liver tissues from normal rats (A1&A2), untreated diabetic rats (B); diabetic rats treated (for 17 days) with total Nigella sativa seeds oil at100mg/kg/day (C), lipid polar (D) and neutral (E) fractions from total Nigella sativa seeds oil at100mg/kg bw/day; thymoquinone at 25 mg/kg bw/day (F) and metformin at 25 mg/kg bw/day (G). Diabetes was induced by N/STZ. Magnification (X425) Slides are stained with haematoxylin and eosin (H&E).
Oedema
Oedema + Infiltration of inflammatory cells respectively, in diabetic rats (groups III, IV and V with 6 animals in each group). The antidiabetic drug metformin (at 25 mg/kg bw/day for 17 days) lead to 18.48% reduction in FBG (group VI, n=7) while thymoquinone (at 25 mg/kg bw/day for 17 days) did not show any significant effect on FBG which was reduced by less than 8% (group VII, n=6). Control normal rats (group I, n=9) and diabetic non treated rats (group I, n=6) were used as controls. Table 1 illustrates the effect of total oil, polar and neutral lipid fractions on AST, ALT, γ-GT and AP enzyme activities and on total biluribin serum titer of diabetic rats at the beginning and at the end of experimental period, 17 days, of treatments (Table 1) . It is clear that the three fractions as well thymoquinone and metformin had no significant effect on the levels of transaminases suggesting that they are not toxic for the liver. We found a significant increase in AST (82.06 ± Sobhi W. et al.: Hepatotoxicity, Langerhans Islets Regenerative Effects of Nigella sativa in Diabetic Rats Apart from metformin that led to nearly 2.6 fold increase γ-GT activity (3.58 ± 0.50 IU/L vs. 1.35 ± 0.22 IU/L for controls), Nigella sativa oil extracts and thymoquinone did not alter the activity of this enzyme demonstrating their non cytolytic hepatic effect. Levels of bilirubin were not affected by treatment with either Nigella sativa oil extracts or the two standard molecules (metformin and thymoquinone). However, a significant drop in the level of bilirubin was noticed with untreated diabetic rats (0.021 ± 0.004 mg/dl vs. 0.067 ± 0.007 mg/dl in controls) ( Table 1) .
Treatment with neutral lipid fraction led to a significant reduction of AP activity, from 332 ± 4.75 IU/L to 186 ± 55.0 IU/L. Treatments with total oil, polar lipid fraction, thymoquinone and metformin did not show any significant changes. However, a significant increase in the activity of this enzyme to 430 ± 74.7 IU/L, was recorded in diabetic non treated rats (Table  1) .
In contrast to the biochemical markers where no obvious indication of any hepatotoxicity by different fractions and molecules were observed, the histopathological analysis showed minor and major hepatic lesions (Figure 1 ). The histology of liver tissue was normal in control rats. Hepatic tissues of this group I present a normal morphological aspect with a lot of lobules, each of which is constituted of hepatocytes separated by small arteries converging towards the centrolobular vein. Lobules are small patches of connective tissue each containing a duct, a large vein, and a small artery which mark the corners where lobules come together, as shown in Figure 1A .
In non-treated diabetic rats, the most consistent findings were the enlargement of the portal area due to the formation of edema ( Figure 1B) . Treated diabetic rats with total oil of Nigella sativa seeds or with the neutral lipid fraction (100 mg/kg bw/day for 17 days) showed, in addition to the enlargement of the portal area observed in non treated rats, inflammatory manifestations due to the infiltration of mononuclear cells ( Figure 1C and Figure 1D respectively) pointing out to the occurrence of hepatic lesions or hepatitis. The histology of livers from group IV, treated with polar lipids at 100 mg/kg bw/day for 17 days, showed no inflammatory cell infiltration ( Figure 1E ). Liver tissue of rats treated with thymoquinone (group VII), 25mg/kg bw/day for 17 days, present an enlargement of the portal area but without inflammatory infiltration ( Figure  1F ). Metformin treatment had minor effect on the liver histology, which appears to be normal with a much reduced enlargement of the portal area and without inflammatory cell infiltration ( Figure 1G ).
Histopathological investigation on pancreatic tissue revealed that the pancreatic islet cells were normal in control rats, a full parenchyma with lobular structure where lobules are separated by connective tissue. The islets are of normal size and surrounded by serous acini ( Figure 2A1 ) and a normal extra-lobular excretory duct ( Figure 2A2 ). In diabetic rats with no treatment, pancreatic tissue is abnormal with lobular atrophy and a marked diminution in number and size of islets ( Figure  2B ) which is a consequence of STZ toxic effect leading to a drop in insulin production and hence development of diabetes.
Pancreatic tissue of diabetic rats treated with total oil (100 mg/kg bw/day for 17 days) presented islets of medium size ( Figure 2C ). An obvious improvement is observed when compared to slides from untreated rats ( Figure 2B ) suggesting a regenerative effect. Treatment with polar lipid fractions from total oil of Nigella sativa seeds (100mg/kg bw/day, for 17 day) gave no improvement with the persistence of islets anomalies ( Figure 2C ). But, in the other hand, a significant improvement was observed with the neutral lipid fraction where islets distinctly increased in size (up to 3 fold) and number ( Figure 2D ). This supports the possibility of a regenerative potential effect of neutral lipids on pancreatic tissue. A more marked increase, particularly in size (up to 5.5 fold), was observed in rats treated with thymoquinone (25mg/kg bw/day, for 17 day) ( Figure 2E ). In contrast, treatment with metformin (25mg/kg/day, for 17 day) had no effect of the recovery in terms of the number and size of the islets ( Figure 2F ).
Discussion
The hypoglycaemia activity of extracts from the seeds of Nigella sativa in general and oils in particular, with emphasis on thymoquinone, the major constituent of volatile oils of the seeds, is well documented (2) (3) (4) (5) 9, 11, 25, 27) . Our data suggest that such hypoglycaemic effect is a result of (i) a hepatic regulation of carbohydrate metabolism (11), (ii) action on the intestinal absorption (5) or (iii) regeneration of insulin producing pancreatic islets (2, 12, 13, 25, 26, 28) . However, little is known about the toxicity of extracts from these seeds. Recently, It has been reported beside the neuroprotective effect of the oil of Nigella sativa seeds and thymoquinone on rats exposed to neurotoxique agents (16) (17) (18) , and a protective effect of beta-cell damage in STZ-induced diabetic rats (28) .
At the end of the experiment (day 17), a significant decrease in blood glucose level was observed in diabetic rats treated with total oil, neutral and polar lipid fractions. In contrast, thymoquinone did not show any significant effect on glycaemia. In a quite similar study, Kanter and coworkers used 0.2ml/kg bw/day of essential oil from Nigella sativa seeds on a one month treatment showed a reduction in blood glucose and an increase in insulin production as a consequence of the regeneration of Langerhans islets (2, 12) .
High concentrations of total oil or thymoquinone from Nigella sativa seeds have been used to show their hypoglycaemiant effect on treated animals in STZ or alloxan induced diabetes (3, 4, 9, 11) .
Despite the fact that liver markers AST, ALT, γ-GT, AP and biluribin did not show any hepatotoxic effect which is in agreement with what has been reported previously, histological studies showed clear and apparent hepatic lesions on liver slides.
Histological comparison between liver tissues from different groups of rats showed that diabetic untreated rats present an enlargement of the portal areas which could be a result of sugar metabolic disorders responsible for hepatic edema. The treatment with either total oil or polar fraction worsens the case by an observed inflammatory cell infiltration in contrast to the recovery, with the reduction in edema size, obtained with the neural fraction. This suggests the presence of a compound (s) in the polar fraction behind the secondary inflammation process (cell infiltration) observed and that the neutral fraction possesses a hepatoprotective effect. Surprisingly, both thymoquinone and metformin did not show any protective effect on the liver of treated diabetic rats. We note that concentrations tested of each treatment: total oil, polar lipid fraction, neutral lipid fraction, thymoquinone and metformin induce a slight histopathological toxic effect, but those lesions could not modify the titer of the hepatic markers.
STZ induces degeneration of the pancreas with a lobular atrophy and a decrease in size and number of Langerhans islets (2, 20) . A recovery on the pancreatic tissues of rats treated with total oil or the neutral of lipid fraction was observed with a size increase of the islets due to either a regeneration and /or proliferation of the islets in contrast to the treatment with the polar fraction which did not show any positive effect, namely persistence of the abnormalities observed in non treated diabetic rats. Slight regenerative and proliferative effects were noticed on the pancreatic tissues of rats treated with thymoquinone but not with metformin.
Published papers support our findings: Meral and his coworkers noticed that Nigella sativa oil improves the antioxidant defense system (reduction in MDA and an increase in GSH and ceruloplasmin), of the liver in alloxan induced diabetes in rabbits with a normal hepatic histology (9) . However, pancreatic slides from diabetic rabbits treated or not with total oil from Nigella sativa seeds showed degeneration, necrosis and infiltration with mononuclear cells beside edema formation (9) . A protective effect of the volatile oil on β cells, by acting on the oxidative stress generated by NO following STZ action on the islets of Langerhans (2, 12, 25) with a light and electron microscopic studies (28) has been reported. Beside the hypoglycaemic effect, extracts from Nigella sativa seeds stimulate insulin production in isolated Langerhans islets (13) .
Pancreatic protective effect of thymoquinone is well documented where the administration of 50mg/kg bw/day to STZ-induced diabetic hamsters reduces not only significantly blood sugar and glycosylated hemoglobin but acts equally on the reduction of gluconeogenesis (11) . It protects the pancreas against NO generated oxidative stress (8) and showed a hepatoprotective effect on cultured hepatocytes (7) . In our study, we observed that the regenerative effect on pancreatic islets of neutral lipid fraction was more important than that of thymoquinone.
In this study, we confirmed the hypoglycemic effect of Nigella sativa seeds oil and showed that it resides mainly on its polar lipid fraction. Although no changes on hepatic enzyme activities and biluribin titer were recorded, histological investigation showed liver damages on diabetic rats treated with Nigella sativa lipid extracts. Neutral lipid fraction of the oil showed a regenerative and/or a proliferative effect on STZ damaged pancreatic islets. This leads us to suggest that the hypoglycemic effect Nigella sativa is partially due to the positive action of the neutral oil fraction on the pancreatic tissue. The action of the polar oil fraction in lowering blood sugar could be explained by other mechanisms such as the action on intestinal sugar metabolism or by the regulation of such metabolism in the liver. The same thing can be stated for the hypoglycemic action of thymoquinone where its involvement on hepatic glycogenesis regulation has been reported (11) .
